Rezultati - Pau Cerdà
- Showing 1 - 2 results of 2
-
1
PI3K (Phosphatidylinositol 3-Kinase) Activation and Endothelial Cell Proliferation in Patients with Hemorrhagic Hereditary Telangiectasia Type 1 od Adriana Iriarte, Albert Figueras, Pau Cerdà, José María Mora, Anna Jucglá, R.M. Penín, Francesc Viñals, Antoni Riera‐Mestre
Izdano 2019Artigo -
2
Beneficial effect of corticosteroids in preventing mortality in patients receiving tocilizumab to treat severe COVID-19 illness od Manuel Rubio‐Rivas, Mar Ronda, Ariadna Padullés, Francesca Mitjavila, Antoni Riera‐Mestre, Carlos G. Forero, Adriana Iriarte, José María Mora, Núria Padullés Zamora, Mònica González, Xavier Solanich, Mercè Gasa, Guillermo Suárez-Cuartín, Joan Sabater‐Riera, Xosé Pérez-Fernández, E Santacana, E. Leiva Badosa, Albert Ariza‐Solé, Paolo Dallaglio, María Quero, Antonio Soriano, Alberto Pasqualetto, Maylin Koo, Virginia Esteve-Luque, Arnau Antolí, Rafael Moreno‐González, Sergi Yun, Pau Cerdà, Mariona Llaberia, Francesç Formiga, Marta Fanlo‐Maresma, Abelardo Montero, David Chivite, Olga Capdevila, Ferrán Bolao, Xavier Pintó, J. M. Llop Talaverón, A. Sabaté, Jordi Guardiola, Josep M. Cruzado, Josep Comín‐Colet, Salud Santos, R. Jódar, Xavier Corbella
Izdano 2020Artigo
Iskalna orodja:
Sorodne teme
Medicine
2019-20 coronavirus outbreak
Biochemistry
Cancer research
Chemistry
Coronavirus disease 2019 (COVID-19)
Disease
Infectious disease (medical specialty)
Intensive care medicine
Internal medicine
Kinase
Outbreak
PI3K/AKT/mTOR pathway
Pathology
Phosphatidylinositol
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
Signal transduction
Telangiectasia
Tocilizumab
Virology